Regional chemotherapy with hemofiltration: A rationale for a different treatment approach to advanced pancreatic cancer

Hepato-Gastroenterology

Volumn 43, Issue 8, 1996, Pages 346-355

  Muchmore, James H ^a   Carter, R Davilene ^a   Preslan, Janet E ^a   George, William J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Advanced pancreatic cancer; Hemofiltration; Regional chemotherapy

Indexed keywords

FLUOROURACIL; MITOMYCIN C; MITOXANTRONE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELIAC ARTERY; CLINICAL ARTICLE; CYSTADENOCARCINOMA; FEMALE; HEMOFILTRATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LEUKOPENIA; LIVER METASTASIS; MALE; PANCREAS CANCER; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CYSTADENOCARCINOMA; FEMALE; HEMOFILTRATION; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; PANCREATIC NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0029940022     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Gud Jonsson. Cancer of the pancreas: 50 years of surgery. Cancer 1987;60:2284-2303.
2. Warshaw AL, Swanson RS. Pancreatic cancer in 1988. Ann Surg 1988;208:541-553.
3. Griffin JF, Smallery SR, Jewell W, Paradelo JC, Reymond RD, Hassanein RES, Evans RG. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990;66:56-61.
4. Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC. Resection Margins in carcinoma of the head of the pancreas. Ann Surg 1993;217:144-148.
5. Satake K, Nishiwaki H, Yokomatsu H, Kawazoe Y, Kim K, Haku A. Surgical curability and prognosis for standard versus extended resection for T carcinoma of the pancreas. Surg Gyn Obstet 1992;175:259-255.
6. Geer RJ, Breunan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 165: 68-73.
7. Cubilla AL, Fortner J, Fitzgerald PJ. Lymph node involvement in carcinoma of the head of the pancreas area. Cancer 1978;41:880-887.
8. Cameron JL, Crist DW, Sitzman JV, Hruban RH, Boitnott JK, Seidler AJ, Coleman J. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991; 161: 120-125.
9. Bottger TC, Storke S, Wellek S, Stockle M, Junginger T. Factors influencing survival alter resection of pancreatic cancer. Cancer 1994; 73: 63-73.
10. Petrek JA, Sandberg WA, Bean PK, Bradley EL. Can survival in pancreatic adenocarcinoma be predicted by primary size or stage? Am Surg 1985; 51: 42-51.
11. Nagakawa T. Regional pancreatectomy in Japan. In: The Fifth International Symposium: Fundamental and clinical research in and biliary tract cancers. Tokyo, Japan: Foundation for Promotion of Cancer Research, 1992, pp. 60-61.
12. Bhuiya MR, Nimura Y, Kamiya J, Kondo S, Fukata S, Hayakawa N, Shionoya S. Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg 1992; 215: 344-349.
13. Kalser MH, Ellengerg SS. Pancreatic cancer: Adjuvant combined radiation and chemotherapy following a curative resection. Arch Surg 1985; 120:899-903.
14. Almoquera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K- ras genes. Cell 1988; 53: 549-554.
15. Capella G, Cronauer-Mitra S, Peinado MA, Perucho M. Freguency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environm Health Perspect 1991; 93: 125-131.
16. Brennan MF, Kinsella TJ, Casper ES. Cancer of the pancreas. In DeVita Jr VT, Hellman S, Rosenberg SA (eds). Cancer, Principles and Practice of Oncology. Philadelphia, JB Lippincott Co, 1993, pp 849-882.
17. Smith FP, Schein PS. Chemotherapy of pancreatic cancer. Semin Oncol 1979;6:368-377.
18. Culliman S, Moertel CG, Wieand HS, Schutt AJ, Krook JE, Foley JF, Norris BD, Kardinal CG, Tschetter LK, Barlow JF. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallison regimen and combined 5-fluorouracil, doxorubicin, and cisplatin. Cancer 1990; 65: 2207-2212.
19. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992; 326: 455-465.
20. Moertel CG, Childs Jr DS, Reitmeier RJ, Colby MY, Holbrook MA. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969; 2: 865-867.
21. Raju PI, Maruyama Y, McDonald J, DeSimone P. Treatment of unresectable pancreatic carcinoma using irradiation with concurrent intravenous 5-FU infusion therapy. Cancer Invest 1988; 6: 263-266.
22. Wagener DJT, van Hoesel QGCM, Yap SH, Hoogenraad WJ, Strijk SP. Phase II trial of 5-fluorouracil, adriamycin, and cisplatin (FAP) followed by radiation and 5-fluorouracil in locally advanced pancreatic cancer. Cancer Chemother Pharmacol 1989; 25: 131-134.
23. Bruckner HW, Kalnicki S, Dalton J, Schwartz GK, Chesser MR, Mandeli J, Janus C. Combined modality therapy increasing local control of pancreatic cancer. Cancer Invest 1993; 11: 241-246.
24. Soehendra N, Grimm H, Berger B, Nam VC. Malignant jaundice: results of diagnostic and therapeutic endoscopy. World J Surg 1989;13:171-177.
25. Beugmark S, Andren-Sandberg A. Infusion chemotherapy in inoperable pancreatic carcinoma. Recent Results Cancer Res 1983;86:13-14.
26. Theodors A, Bukowski RM, Hewlett JS, Livingston RB, Weick JK. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma, Phase I and II pilot study. Am J Clin Oncol 1982; 5:555-558.
27. Aigner KR, Muller H, Bessermann R. Intra-arterial chemotherapy with MMC, CDDP and 5-FU for non-resectable pancreatic cancer-A phase II study. Reg Cancer Treat 1990;3:1-6.
28. Dedrick RL, Oldfield EH, Collins JH. Arterial drug infusion with extracorporeal removal. Theoretical basis with particular reference to the brain. Cancer Treat Rep 1984;68:373-380.
29. Aigner KR, Thiller H, Walter H, Link KH. Drug filtration in high-dose regional chemotherapy. Contr Oncol 1988;29:261-280.
30. Muchmore JH, Krementz ET, Carter RD, Meyer GM, Preslan JE, George WJ. Management of advanced intra-abdominal malignancy using high-dose intra-arterial chemotherapy with concomitant hemofiltration. Reg Cancer Treat 1990;3:211-215.
31. Muchmore JH, Krementz ET, Carter RD, Preslan JE, George WJ. Treatment of abdominal malignant neoplasms using regional chemotherapy with hemofiltration. Arch Surg 1991;126:1390-1396.
32. den Hartigh J, Van Orr WJ. High performance liquid chromatography determination of the anti-tumor agent Mitomycin C in human blood plasma. Anal Chim Acta 1981;127:47-53.
33. Stein TA, Burns GP, Bailey B, Wise L. Measurement of 5- fluorouracil and its metabolites in tissue. J Chromatoghr 1990;507:259-265.
34. Tyler DS, Evans DB. Reoperative pancreaticoduodenectomy Ann Surg 1994;219:211-221.
35. Hoffman JP, Weese JL, Solin LJ, Agarwal P, Engstrom P, Scher R, Paul AR, Litwin S, Watts P, Eisenberg BL. A single institutional experience with preoperative chemoradiotherapy for Stage I-III pancreatic adenocarcinoma. Am Surg 1993;59:772-781.
36. Warshaw AL. Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 1991;161:26-30.
37. Pilepich MV, Miller HH. Preoperative irradiation in carcinoma of the pancreas. Cancer 1980;46:1945-1949.
38. Kopelson G. Curative surqery for adenocarcinoma of the pancreas/ampulla of Vater: The role of adjuvant pre- or postoperative radiation therapy. Int J Rad Oncol Biol Physics 1983;9:911-915.